Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phase Two”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00274469
What this trial is testing

A Clinical Trial to Compare Efficacy and Tolerability of Faslodex With Arimidex in Patients With Advanced Breast Cancer

Who this might be right for
Metastatic Breast Cancer
AstraZeneca 205
Testing effectiveness (Phase 2)Study completedNCT02653976
What this trial is testing

SP-02L in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

Who this might be right for
Peripheral T-Cell Lymphoma
Solasia Pharma K.K. 67
Early research (Phase 1)Not Yet RecruitingNCT07739017
What this trial is testing

OLIG2 Inhibitor CT-179 for Recurrent and Newly-diagnosed Glioblastoma

Who this might be right for
Recurrent GlioblastomaNewly Diagnosed MGMT Unmethylated Glioblastoma
Olivia Newton-John Cancer Research Institute 54
Testing effectiveness (Phase 2)Study completedNCT00322517
What this trial is testing

Study Of The Efficacy And Safety Of SU-014813 In Patients With Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
Pfizer 90
Testing effectiveness (Phase 2)Looking for participantsNCT06377540
What this trial is testing

MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma

Who this might be right for
Autologous Stem Cell TransplantClassic Hodgkin Lymphoma
Masonic Cancer Center, University of Minnesota 28
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06166589
What this trial is testing

Second-line Zimberelimab and SIRIOX Chemotherapy for Patient With Previously AG Chemotherapy Treated Pancreatic Cancer

Who this might be right for
Previously AG Chemotherapy Treated Pancreatic Cancer
Shanghai Zhongshan Hospital 19
Testing effectiveness (Phase 2)Ended earlyNCT01413750
What this trial is testing

Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Stage IIIA Lung Non-Small Cell Cancer AJCC v7Stage IIIB Lung Non-Small Cell Cancer AJCC v7Stage IV Lung Non-Small Cell Cancer AJCC v7
National Cancer Institute (NCI) 23
Testing effectiveness (Phase 2)Study completedNCT02296190
What this trial is testing

Efficacy and Safety of Intranasal MSP-2017 (Etripamil) for the Conversion of PSVT to Sinus Rhythm

Who this might be right for
Paroxysmal Supraventricular Tachycardia (PSVT)
Milestone Pharmaceuticals Inc. 199
Testing effectiveness (Phase 2)Study completedNCT00006890
What this trial is testing

Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
NCIC Clinical Trials Group 67
Testing effectiveness (Phase 2)Study completedNCT00624910
What this trial is testing

Efficacy and Safety of a Collagen Bupivacaine Implant in Women Following Abdominal Hysterectomy

Who this might be right for
Postoperative Pain
Innocoll 54
Testing effectiveness (Phase 2)Ended earlyNCT05583110
What this trial is testing

Efficacy and Safety of the Combination of Trastuzumab Plus TUCAtinib Plus viNorelbine in Patients With HER2-positive Non-resectable Locally Advanced or Metastatic Breast Cancer

Who this might be right for
HER2-positive Metastatic Breast CancerLocally Advanced HER2 Positive Breast Carcinoma
Spanish Breast Cancer Research Group 13
Testing effectiveness (Phase 2)Ended earlyNCT01499160
What this trial is testing

Letrozole and Lapatinib Followed by Everolimus in Women With Advanced Breast Cancer

Who this might be right for
Breast NeoplasmsEndocrine Breast DiseasesNeoplasm Metastasis
University of Maryland, Baltimore 7
Testing effectiveness (Phase 2)Study completedNCT00685360
What this trial is testing

A Trial to Evaluate OPC 67683 in Participants With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB)

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug ResistantExtensively Drug-Resistant Tuberculosis
Otsuka Pharmaceutical Development & Commercialization, Inc. 481
Testing effectiveness (Phase 2)Looking for participantsNCT07269782
What this trial is testing

A Phase II Study to Evaluate the Efficacy and Safety of HLX43 + Serplulimab as Neoadjuvant Therapy in Subjects With NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Shanghai Henlius Biotech 60
Testing effectiveness (Phase 2)Ended earlyNCT00200382
What this trial is testing

Phase II Study of Therapy With PS 341 in Patients With Advanced Stage Non Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Rasim Gucalp 27
Testing effectiveness (Phase 2)Ended earlyNCT03002623
What this trial is testing

CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer

Who this might be right for
Thyroid NeoplasmsPoorly Differentiated and Undifferentiated Thyroid CancerDifferentiated Thyroid Cancer
National Cancer Institute (NCI) 7
Testing effectiveness (Phase 2)Looking for participantsNCT07110246
What this trial is testing

Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas

Who this might be right for
BRAF V600 MutationLow-grade GliomaLow Grade Glioma of Brain+1 more
University of California, San Francisco 96
Testing effectiveness (Phase 2)Active Not RecruitingNCT06790862
What this trial is testing

A Trial of SHR0302Base in Patients With Vitiligo

Who this might be right for
Vitiligo
Jiangsu HengRui Medicine Co., Ltd. 155
Testing effectiveness (Phase 2)Looking for participantsNCT06568562
What this trial is testing

XL092 in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
University of Utah 32
Testing effectiveness (Phase 2)Study completedNCT00640523
What this trial is testing

Phase II Study of Forodesine in Subjects With Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
BioCryst Pharmaceuticals 23
Next Page